Ameriprise’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,269
| Closed | -$43.1K | – | 3920 |
|
|
2024
Q2 | $43.1K | Sell |
16,269
-2,000
| -11% | -$5.3K | ﹤0.01% | 3823 |
|
|
2024
Q1 | $50.1K | Buy |
+18,269
| New | +$50.1K | ﹤0.01% | 3813 |
|
|
2023
Q4 | – | Sell |
-15,300
| Closed | -$30.9K | – | 3901 |
|
|
2023
Q3 | $30.9K | Hold |
15,300
| – | – | ﹤0.01% | 3855 |
|
|
2023
Q2 | $45.1K | Buy |
15,300
+3,664
| +31% | +$10.8K | ﹤0.01% | 3865 |
|
|
2023
Q1 | $29.1K | Sell |
11,636
-22,911
| -66% | -$57.3K | ﹤0.01% | 3886 |
|
|
2022
Q4 | $110K | Buy |
34,547
+5
| +0% | +$16 | ﹤0.01% | 3800 |
|
|
2022
Q3 | $102K | Buy |
+34,542
| New | +$102K | ﹤0.01% | 3818 |
|
|
2022
Q2 | – | Sell |
-584,550
| Closed | -$7.89M | – | 3888 |
|
|
2022
Q1 | $7.89M | Buy |
584,550
+156,250
| +36% | +$2.11M | ﹤0.01% | 2093 |
|
|
2021
Q4 | $5.58M | Sell |
428,300
-13,820
| -3% | -$180K | ﹤0.01% | 2389 |
|
|
2021
Q3 | $4.15M | Buy |
+442,120
| New | +$4.15M | ﹤0.01% | 2516 |
|